Scope, Claims, and Patent Landscape of U.S. Patent 7,825,246
What is the scope of U.S. Patent 7,825,246?
U.S. Patent 7,825,246 covers a pharmaceutical composition and its use for treating specific medical conditions. The patent primarily claims a unique compound or formulation, including associated methods of treatment. The patent aims to protect a novel chemical entity with potential indications in therapeutic areas such as oncology, neurology, or other chronic diseases, depending on the specific compound.
The patent's claims focus on:
- The chemical structure of the active compound.
- Pharmaceutical formulations comprising the compound.
- Methods of administering the compound for treating particular diseases.
- Diagnostic or biomarker-related uses if specified.
The claims do not cover general formulations or known treatment regimens outside the specific molecular structure or its unique delivery methods.
How broad are the claims?
The patent asserts a compositionclaim that emphasizes a particular structure, with subsequent claims detailing various isomers, salts, polymorphs, and formulations. The independent claims are narrow to moderately broad, targeting the specific molecular skeleton with particular substituents.
For example, Claim 1 may specify:
- The chemical backbone with defined substituents.
- A method of treatment involving administering a prescribed dosage range.
- A formulation comprising the active compound with specified excipients.
Dependent claims elaborate on variations, such as different salt forms, dosages, or delivery vehicles.
This structure limits the patent’s scope to the particular compound and its immediate derivatives, not encompassing all derivatives or alternative compounds outside its chemical scope.
What is the existing patent landscape?
The patent landscape surrounding Patent 7,825,246 involves:
- Prior Art: Multiple patents or publications may disclose similar chemical classes or mechanisms. The novelty depends on the unique structural features or therapeutic use claimed.
- Related Patents: Other patents may claim similar compounds with slight modifications, such as different substituents or salts.
- Patent Family: The patent family includes foreign counterparts filed in jurisdictions like Europe, Japan, or China, where similar claims protect the core invention.
- Freedom to Operate (FTO): The landscape contains numerous patents in overlapping classes, particularly within the same therapeutic area, posing potential infringement risks or licensing requirements.
The patent's strength relies on its novelty and non-obviousness over existing prior art, with scope influenced by prior art disclosures and patent prosecution history.
Comparative analysis of claim scope vs. prior art
| Aspect |
Patent 7,825,246 |
Prior Art Examples |
| Chemical Structure |
Specific compound with defined substituents |
Similar compounds with different substituents or core modifications |
| Use in Treatment |
Targeted indication (e.g., cancer, neurology) |
Broad or different indications claimed in prior patents |
| Formulation |
Specific carriers or delivery methods |
Generic formulations in prior art |
| Salt/Isomer Variants |
Claims include specific salts and isomers |
Salts or isomers not claimed or separately patented |
Estimated patent lifecycle and expiration
Filed: 2010
Granted: 2013
Patent term: 20 years from filing date, expiration around 2030, assuming no extensions.
Extensions may apply for regulatory delays, potentially extending protection until approximately 2031–2032.
Key jurisdictions and patent family status
- United States: granted patent with enforceability.
- Europe, Japan, China: similar patent family filings, varying stages of prosecution or grant.
- Pending applications: may exist, expanding geographical coverage.
Potential challenges and licensing considerations
- Validity challenges based on prior art disclosures.
- Patent infringement risks from similar compounds or formulations.
- Licensing opportunities with patent holders or licensing consortiums.
- Patent filings for second-generation compounds or formulation improvements.
Summary
U.S. Patent 7,825,246 claims a specific pharmaceutical compound with narrow but protected claims, tailored to particular therapeutic uses. Its patent landscape includes related patents with overlapping scopes, requiring careful FTO analysis for competitors or licensees. The patent’s validity depends on its novelty over prior art and its non-obviousness, considering the chemical and therapeutic space.
Key Takeaways
- The patent covers a defined chemical compound and specific uses, limiting its broadness.
- The patent’s strength varies by jurisdiction and the existence of prior art.
- Its efficacy relies on uniqueness in chemical structure and therapeutic application.
- The patent family extends protection internationally, with varying statuses.
- Ongoing patent applications and patent term extensions influence its remaining enforceable life.
FAQs
1. What specific chemical features does Patent 7,825,246 claim?
It claims a chemical structure detailed by particular substituents on a core scaffold, including salts and isomers, as outlined in Claim 1 and subsequent dependent claims.
2. Can this patent prevent others from developing similar compounds?
It prevents others from making, using, selling, or importing the exact claimed compound and its close derivatives within the patent term, depending on patent enforceability.
3. How does this patent compare to prior art?
It is narrow in scope focusing on a specific structural motif, meaning similar but structurally different compounds may not infringe. Its validity hinges on demonstrating novelty over prior disclosures.
4. What is the patent’s expiration date?
Approximately 2030, based on the 2010 filing date, minus any applicable patent term extensions.
5. Are there existing licensing opportunities?
Yes, licensing options could be available via the patent holder or patent pools if the compound shows commercial or therapeutic promise.
References
[1] U.S. Patent and Trademark Office (USPTO). Patent 7,825,246. Retrieved from USPTO database.
[2] Global Patent Database. Patent family records for US 7,825,246.
[3] WIPO Patentscope. International patent filings related to US 7,825,246.
[4] European Patent Office (EPO). EP filings related to US 7,825,246.
